期刊文献+

多奈哌齐治疗阿尔茨海默病的临床观察 被引量:7

Clinical observation of effect of donepezil in treating Alzhemer's disease
下载PDF
导出
摘要 目的探讨多奈哌齐对阿尔茨海默病患者认知功能和日常生活能力的治疗作用。方法收集阿尔茨海默病患者140例,随机分为治疗组70例与对照组70例,治疗组采用多奈哌齐,对照组不使用多奈哌齐治疗。两组患者分别在治疗前、治疗后1个月、3个月、6个月进行MMSE和ADL评分。结果治疗组经多奈哌齐治疗后MMSE和ADL评分较对照组有明显改善,随治疗时间延长两组间差异增大即治疗作用增强,且均具有统计学差异(P<0.05)。治疗1个月、3个月和6个月后,多奈哌齐对AD患者认知功能改善的总体有效率分别高出对照组13%、32%、43%,对日常生活能力改善的总体有效率分别分别高出对照组8%、13%、23%,与对照组相比多奈哌齐疗效显著(P<0.05)。结论多奈哌齐对阿尔茨海默病患者认知和日常生活能力有显著改善作用。 Objective To investigate the effect of donepezil in treating patients with Alzheimer's disease on cognitive disfunction and lacking of capablity of daily living.Methods140 patient's with Alzheimer's disease were randomly divided into treatment group(treated with donepezil)and control group(treated without donepezil).MMSE Scale and ADL Scale of the two groups were assessed before treatment and 1 months、3 months and 6 months af ter treatment.ResultsThe MMSE Scale and ADL Scale of the treatment group were improved more greatly than the control group(P0.05),and the therapeutical effect enhanced as the time of therapy expanded.After treated with donepezil for 1 month、2 months、6 months,the effective percentage of donepezil in treating AD patients with congnitive disfunction are respectively13%、32%、43%hgher than without donepezil,and in treating AD patients lacking of capablity of daily living are respectively 8%、13%、23%hgher than without donepezil.ConclusionDonepezil effectively improves cognition and preserves function in individuals with Alzheimer's disease.
出处 《中国实用医药》 2010年第12期22-23,共2页 China Practical Medicine
关键词 多奈哌齐 阿尔茨海默病 Donepezil Alzheimer's disease
  • 相关文献

参考文献7

  • 1Samanta MK, Wilson B, Santhi K, et al. Alzheimer disease and its management : a review. Am J Ther,2006,13 (6) :516-526.
  • 2Folstein MF, Folstein SE, McHugh PR. "Mini-mental state" : a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 1975,12 : 189-98.
  • 3Galasko D, Bennett D, Sano M, et al. An inventory to assessactivities of daily living for clinical trials in Alzheimer' s disease. Alzheimer Dis Assoc Disord, 1997,11 ( suppl 2):S33-39.
  • 4Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer' s disease:revising the NINCDS-ADRDA criteria. Lancet Neurol,2007,6 ( 8 ) :734-746.
  • 5American Psychiatric Association. Diagnostic and statistical manual of mental disorders,4th edn. Washington:American Psychiatric Association, 1994.
  • 6胡锦芳,熊玉卿.多奈哌齐抗阿尔茨海默病的药理及临床研究进展[J].药品评价,2008,5(5):233-236. 被引量:11
  • 7Winblad B, Kilander L, et al. Donepezil in patients with severe Alzheimer' s disease : double-blind, parallel-group, placebo-controlled study, Lancet 2006,367 : 1057-1065.

二级参考文献13

共引文献10

同被引文献44

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部